<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Txt>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE335nnn/GSE335568/suppl/filelist.txt</Txt><Raw>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE335nnn/GSE335568/suppl/GSE335568_RAW.tar</Raw><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE335nnn/GSE335568/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><species>Homo sapiens</species><gds_type>Genome binding/occupancy profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE335568</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>The FGF4–integrin β1 axis orchestrates diabetic wound regeneration by restoring directional collective motility.</name><description>This dataset was generated to investigate the mechanisms underlying the pro-healing effects of Fibroblast Growth Factor 4 (FGF4) on diabetic wounds. We performed RNA sequencing on wound tissues from streptozotocin (STZ)-induced diabetic mice. The mice received daily topical applications of either recombinant FGF4 (rFGF4) or PBS vehicle control. Wound tissues were harvested on day 7 post-wounding for transcriptomic analysis.</description><dates><publication>2026/06/18</publication></dates><accession>GSE335568</accession><cross_references><GSM>GSM9815740</GSM><GSM>GSM9815738</GSM><GSM>GSM9815739</GSM><GPL>34284</GPL><GSE>335568</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>